Skip to main content
SpringerLink
Log in

Structure-Activity Correlations of Natural Products with Anti-HIV Activity

  • Chapter
Natural Products as Antiviral Agents

Abstract

The search for safe and effective therapies to treat infections caused by the human immunodeficiency virus (HIV) and related opportunistic infections (OI’s) are among the highest priorities of the National Institutes of Health. The Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID) supports rational drug design and targeted drug discovery for HIV and the OI’s through investigator-initiated research grants including the National Cooperative Drug Discovery Group programs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. McGowan, and D. Hoth, AIDS drug discovery and development, J. AIDS 2:355 (1989).

    Google Scholar 

  2. O.S. Weislow, R. Kiser, D.L. Fine, J. Bader, R.H. Shoemaker, and M.J. Boyd, New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity, J. Nat. Cancer Inst. 81:577 (1989).

    Article  PubMed  CAS  Google Scholar 

  3. H. Mitsuya, K.J. Weinhold, P.A. Furman, M.H. St. Clair, S.N. Lehrman, R.C. Gallo, D. Bolognesi, D.W. Barry, and S. Broder, 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of Human T-lymphotropic Virus Type III/lymphadenopathy-Associated Virus In Vitro. Proc. Natl. Acad. Sci. USA 82:7096 (1985).

    Article  PubMed  CAS  Google Scholar 

  4. M.A. Fischl, D.D. Richman, M.H. Grieco, M.S. Gottlieb, P.A Volberding, O.L. Laskin, J.M. Leodom, J.E. Groopman, D. Mildvan, R.T. Schooley, G.G. Jackson, D.T. Durack, and D. King, The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial, N. Engl. J. Med. 317:185 (1987).

    Article  PubMed  CAS  Google Scholar 

  5. W. Ostertag, G. Roesler, C.J. Krieg, J. Kind, T. Cole, T. Crozier, G. Gaedicke, G. Steinheider, N. Kluge, and S. Dube, Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus, Proc. Natl. Acad. Sci., USA, 71:4980 (1974).

    Article  PubMed  CAS  Google Scholar 

  6. S.K. Dube, I.B. Pragneil, N. Kluge, G. Graedicke, G. Steinheider, and W. Ostertag, Induction of endogenous and of spleen focus-forming viruses during dimethylsulfoxide-induced differentiation of mouse erythroleukemia cells transformed by spleen focus-forming virus, Proc. Natl. Acad. Sci., USA, 72:1863 (1975).

    Article  PubMed  CAS  Google Scholar 

  7. W.W. Lee, A. Benitez, L. Goodman, and B.R. Baker, Potential anticancer agents. XL. Synthesis of the.beta.-anomer of 9-(D-arabinofuranosyl)adenine, J. Am. Chem. Soc. 82:2648 (1960).

    Article  CAS  Google Scholar 

  8. F. Cimino, S. De Rosa and S. De Stefano, Antiviral agents from a gorgonian, Eunicella cavolini, Experientia 40:339 (1984).

    Article  CAS  Google Scholar 

  9. J.M. Betz and A.H. Der Marderosian, Antiviral/antineoplastic agents from a jellyfish (Stomolophus meleagris L. Agassiz 1860). Abstract No. 113, Twenty-

    Google Scholar 

  10. W. Bergmann and R. Feeney, Contributions to the study of marine products XXXII. The nucleosides of sponges, J. Org. Chem. 16:981 (1951).

    Article  CAS  Google Scholar 

  11. W. Bergmann and D.C. Burke, Contributions to the study of marine products XXIX. Spongothymidine and spongouridine, J. Org. Chem. 20:1501 (1955).

    Article  CAS  Google Scholar 

  12. M. Nasr, C. Litterst and J. McGowan, Computer-assisted structure-activity correlations of dideoxynucleoside analogs as potential anti-HIV drugs, Antiviral Res., 14:125 (1990).

    Article  PubMed  CAS  Google Scholar 

  13. G. Ahluwalia, D.A. Cooney, H. Mitsuya, A. Fridland, K.P. Flora, Z. Hoa, M. Dalai, S. Broeder and D.J. Johns, Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity, Biochem. Pharmacol., 36:3797 (1987).

    Article  PubMed  CAS  Google Scholar 

  14. N. Shimada, S. Hasegawa, T. Harada, T. Tomisawa, A. Fujii and T.J. Takita, Oxetanocin, a novel nucleoside from bacteria, J. Antibiot. 39:1623 (1986).

    Article  PubMed  CAS  Google Scholar 

  15. T. Maruyama, Y. Sato, T. Horii, H. Shiota, K. Nitta, T. Shirasaka, H. Mitsuya and M. Honjo, Synthesis and antiviral activities of carbocyclic oxetanocin analogues, Chem. Pharm. Bull (Tokyo) 38(10):2719 (1990).

    Article  PubMed  CAS  Google Scholar 

  16. H. Hoshino, N. Shimizu, N. Shimada, T. Takita and T.J. Takeuuchi, Inhibition of infectivity of human immunodeficiency virus by oxetanocin, J. Antibiot. 40:1077 (1987).

    Article  PubMed  CAS  Google Scholar 

  17. J. Seki, N. Shimada, K. Takahashi, T. Takita, T. Takeuchi and H. Hoshino, Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds, Antimicrob. Agents Chemother. 33(5):773 (1989).

    Article  PubMed  CAS  Google Scholar 

  18. Y. Nishiyama, N. Yamamoto, K. Takahasi and N. Shimada, Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G, Antimicrob. Agents Chemother. 32:1053 (1988).

    Article  PubMed  CAS  Google Scholar 

  19. J. Seki, T. Takeuchi, N. Shimada, K. Takahasi, T. Takita, H. Hoshino, Anti-HIV activities of a novel nucleoside oxetanocin and its derivatives, 5th International Conference on AIDS, Montreal, June 4–9, 1989; M.C.P. 121:562 (1989).

    Google Scholar 

  20. D.W. Norbeck, E. Kern, S. Hayashi, W. Rosenbrook, H. Sham, T. Herrin, J.J. Plattner, J. Erickson, J. Clement, R. Swanson, N. Shipkowitz, D. Hardy, K. Marsh, G. Arnett, W. Shannon, S. Broder and H. Mitsuya, Cyclobut-A and cyclobut-G: Broad-spectrum antiviral agents with potential utility for the therapy of AIDS, J. Med. Chem. 33:1281 (1990).

    Article  PubMed  CAS  Google Scholar 

  21. R. Vince, M. Hua, J. Brownell, S. Daluge, F. Lee, W.M. Shannon, G.C. Lavelle, J. Quails, O.S. Weislow, R. Kiser, P.G. Canonico, H. Schultz, V. Narayanan, J.G. Mayo, R.H. Shoemaker and M.R. Boyd, Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virua in vitro. Biochem. Biophys. Res. Commun.156(2): 1046 (1988).

    Article  PubMed  CAS  Google Scholar 

  22. N.V. Heyden, C. Rodi and L. Ratner, Analogs of 3′-deoxyadenosine inhibit HIV-1 replication, AIDS Res. Hum. Retroviruses 5(6):647 (1989).

    Article  Google Scholar 

  23. A.R. Maguire, W.-D. Meng, S.M. Roberts and A.J. Willetts, The preparation of 4′-fluoronucleoside Analogues with potential anti-HIV activity, Abstracts: MRC AIDS Directed Programme Workshop, University of Warwick (1991).

    Google Scholar 

  24. H. Maag, N. Chu, D. Crawford-Ruth, E. Eugui, M.J. McRoberts, A. Mirkovich, M. Pettibone, E.J. Prisbe, R.M. Rydzewski and J.P.H. Verheydin, 4′-Azidothymidine: Synthesis and in vitro anti-HIV activity, Antiviral Res. Suppl. 1:43 (1991).

    Google Scholar 

  25. M. Baba, E. De Clercq, H. Tanaka, et al., Highly potent and selective inhibition of HIV-1 by a novel series of 6-substituted acyclouridine derivatives, Mol. Pharmacol. 39:805 (1991).

    PubMed  CAS  Google Scholar 

  26. U. Weiss, L. Merlini and G. Nasini, Naturally occurring perylenequinones, Progress in the Chemistry of Organic Natural Products, 52:1 (1987).

    PubMed  CAS  Google Scholar 

  27. D.E. Pisani, A.J. Elliott, D.R. Hinman, L.M. Aaronson and R.S. Pardini, Relationship between inhibition of mitochondrial respiration by naphthoquinones, their antitumor activity, and their redox potential, Biochem. Pharmacol. 35(21):3791 (1986).

    Article  PubMed  CAS  Google Scholar 

  28. H.W. Moore, R. Czerniak and A. Hamdan, Natural quinones as quinonemethide precursors — ideas in rational drug design, Drugs Exptl. Clin. Res. XII(6/7):475 (1986).

    Google Scholar 

  29. M.M. Wick and G. Fitzgerald, Inhibition of reverse transcriptase by tyrosinase generated quinones related to levodopa and dopamine, Chem.-Biol. Interactions 38:99 (1981).

    Article  CAS  Google Scholar 

  30. G. Lavie, F. Valentine, B. Levin, Y. Mazur, G. Gallo, D. Lavie, D. Weiner and D. Mervolo, Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin, Proc. Natl. Acad. Sci. USA, 86:5963 (1989).

    Article  PubMed  CAS  Google Scholar 

  31. R. Schinazi, C.K. Chu, J.R. Babu, B.J. Oswald, V. Sallaman, D.L. Cannon, B. Eriksson and M. Nasr, Anthraquinones as a new class of antiviral agents against human immunodeficiency virus, Antiviral Res. 13:265 (1990).

    Article  PubMed  CAS  Google Scholar 

  32. G. Lavie, Y. Mazur, D. Lavie, B. Levin, Y. Ittah and D. Meruelo, Hypericin as an antiretroviral agent: mode of action and related analogues, Proc. Natl. Acad. Sci. USA, 616:556 (1990).

    Article  Google Scholar 

  33. J.F. Davies, Z. Hostomska, S.R. Jordan and D.A. Matthews, Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase, Science, 252:88 (1991).

    Article  PubMed  CAS  Google Scholar 

  34. A. Tanaka, H. Nakashima, O. Yoshida, N. Yamamoto, O. Tenmyo and T. Oki, Inhibitory effect of new antibiotic, pradimicin A on infectivity, cytopathic effect and replication of human immunodeficiency virus in vitro. J. Antibiot. XLI(11): 1708 (1988).

    Google Scholar 

  35. T. Takeuchi, T. Hara, M. Hamada, H. Yamamoto, S. Gomi, Y. Orikasa, M. Sezaki, S. Kondo and H. Yamaguchi, Benanomicins A and B, novel antifungal antibiotics, Abstracts of the 28th ICAAC (1988).

    Google Scholar 

  36. H. Nakashima, N. Yamamoto, Y. Inouye and S. Nakamura, Inhibition by doxorubicin of human immuno-deficiency virus (HIV) infection and replication in vitro, J. Antibiot. XL(3):396 (1987).

    Article  Google Scholar 

  37. I. G. Filion and R. Gaudreault, Effect of daunorubicin on HIV-1 Infected U937 and HUT 78 cells, Abstracts of the 1990 ICAAC, 175 (1990).

    Google Scholar 

  38. S.-I. Ito, G. Gilljams, B. Wahren, H. Wigzell, N. Yamamoto, K. Sasaki and K. Onodera, Inhibition of HIV replication by 19-O-n-pentyldamavaricin Fc in vitro. J. Antibiot. 43(8): 1045 (1990).

    Article  PubMed  CAS  Google Scholar 

  39. K. Ono, H. Nakane, S. Shimizu and S. Koshimura, Inhibition of HIV-reverse transcriptase activity by asterriquinone and its analogues, Biochem. Biophys. Res. Commun. 174(1):56 (1991).

    Article  PubMed  CAS  Google Scholar 

  40. P.S. Sarin, D. Sun, A. Thornton and W.E.G. Muller, Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-T-Lymphotropic retrovirus/lymphadenopathy-associated virus) by Avarol and Avarone. J. Nat. Cancer Inst. 78(4), 663–666. (1987).

    PubMed  CAS  Google Scholar 

  41. F. Reusser, W. Tarpley and I.W. Althaus, Inhibitors of HIV-reverse transcriptase to treat AIDS. U.S. Patent — Upjohn Co. PCT/US88/03114 (1989).

    Google Scholar 

  42. M. Asanaka, T. Kurimura, H. Toya and K. Kato, Screening of anti-HIV activities in existing drugs which are capable of long-term oral administration. Chemotherapy, 38(3):249 (1990).

    CAS  Google Scholar 

  43. S. Loya and A. Hizi, The inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivatives, FEBS Letters 269(1): 131 (1990).

    Article  PubMed  CAS  Google Scholar 

  44. S. Loya, R. Tal, Y. Kashman and A. Hizi, Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase, Antimicrob. Agents Chemother., 34(10):2009 (1990).

    Article  PubMed  CAS  Google Scholar 

  45. M. Lemaitre, D. Guetard, Y. Henin, L. Montagnier and A. Zerial, Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells, Res. Virol. 141:5 (1990).

    Article  PubMed  CAS  Google Scholar 

  46. J. Tang, J.M. Colacino, S.H. Larsen and W. Spitzer, Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses, Antiviral Res. 13:313 (1990).

    Article  PubMed  CAS  Google Scholar 

  47. G. Tachedjian, D. Tyssen, S. Locarnini, I. Gust and C. Birch, Investigation of topoisomerase inhibitors for activity against human immunodeficiency virus; inhibition by coumermycin A1, Antiviral Chem. Chemother. 1(2):131 (1990).

    CAS  Google Scholar 

  48. A. Tanabe-Tochikura, T.S. Tochikura, O. Yoshida, T. Oki and N. Yamamoto, Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan, Virology 176:467 (1990).

    Article  PubMed  CAS  Google Scholar 

  49. G.A. Kraus, D. Pratt, J. Tossberg and S. Carpenter, Antiretroviral activity of synthetic hypericin and related analogs, Biochem. Biophys. Res. Commun. 172(1): 149 (1990).

    Article  PubMed  CAS  Google Scholar 

  50. T. Xiaoshan, C. Hongshan and Z. Xingquan, Inhibition of human immunodeficiency virus reverse transcriptase by Chinese medicines in vitro. Proc. Chin. Acad. Med. Sci. 5(3):140 (1990).

    Google Scholar 

  51. P.H. Dorsett, E.E. Kerstine and L.J. Powers, Antiviral activity of gossypol and apogossypol, J. Pharm Sci. 64:1073 (1975).

    Article  PubMed  CAS  Google Scholar 

  52. K. Wichmann, A. Vaheri and T. Luukkainen, Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent, Am. J. Obestet. Gynecol. 142:593 (1982).

    CAS  Google Scholar 

  53. T.-S. Lin, B.P. Schinazi, B.P. Griffith, E.M. August, B.F. Eriksson, D.-K. Zheng, L. Huang, W.H. Prusoff, Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypol, Antimicrob. Agents Chemother. 33(12):2149 (1989).

    Article  PubMed  CAS  Google Scholar 

  54. R.E. Royer, R.G. Mills, L.M. Deck, G.J. Mertz and D.L. Vanderjagt, Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol, Pharmacol. Res. 24(4):407 (1991).

    Article  PubMed  CAS  Google Scholar 

  55. R.S. Chang, L. Ding, C. Gai-Qing, P. Qi-Choa, Z. Ze-Lin and K.M. Smith, Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus, Proc. Soc. Exp. Biol. Med. 197(1):59 (1991).

    PubMed  CAS  Google Scholar 

  56. K.R. Gustafson, M.H.G. Munro, J.W. Blunt, J.H. Cardellina II, J.B. McMahon, R.J. Gulakowski, C.M. Cragg, P.A. Cox, L.S. Brinen, J. Clardy and M.R. Boyd, HIV inhibitory natural products. 3. Diterpenes from Homolanthus acuminatus and Chrysobalanus icaco. Tetrahedron 47(26):4547 (1991).

    Article  CAS  Google Scholar 

  57. M. Ito, H. Nakashima, M. Baba, R. Pauwels, E. De Clercq, S. Shigeta and N. Yamamoto, Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)], Antiviral Res. 7:127 (1987).

    Article  PubMed  CAS  Google Scholar 

  58. K. Hirabayashi, S. Iwata, H. Matsumoto, T. Mori, S. Shibata, M. Baba, M. Ito, S. Shigeta, H. Nakashima and N. Yamamoto, Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type I (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chem. Pharm. Bull. 39(1): 112 (1991).

    Article  PubMed  CAS  Google Scholar 

  59. M. Ito, A. Sato, K. Hirabayashi, F. Tanabe, T.S. Shigeta, M. Baba, E. De Clercq, H. Nakashima and N. Yamamoto, Inhibitory effect of glycyrrhizin on replication of HIV, Antiviral Res. 10:289 (1988).

    Article  PubMed  CAS  Google Scholar 

  60. H. Kazuhiro, I. Susamu, M. Hiroatsu, M. Takeo, S. Shoji, B. Masanori, I. Masahiko, S. Shiro, N. Hideki and N. Yamamot, Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chem. Pharm. Bull. 39(1): 112 (1991).

    Article  Google Scholar 

  61. B. Polsky, SJ. Segal, P.A. Baron, J.W. Gold, H. Ueno and D. Armstrong, Inactivation of human immunodeficiency virus in vitro by gossypol, Contraception 39(6):579 (1989).

    Article  PubMed  CAS  Google Scholar 

  62. B.C.M. Potts, D.J. Faulkner, J.A. Chen, G.C. Simolike, P. Offen, M.E. Hemling and T.A. Francis, T.A., Didemnaketals A and B, HIV-1 protease inhibitors from the Ascidian Didemnum sp., J. Am. Chem. Soc. 113:6312 (1991).

    Article  Google Scholar 

  63. H. Nakashima, K. Okubo, Y. Honda, T. Tamura, S. Matsuda, N. Yamamoto, Inhibitory effect of glycosides like saponin from soybean on the infectivity of HIV in vitro, AIDS 3(10):655 (1989).

    Article  PubMed  CAS  Google Scholar 

  64. E. De Clercq, New selective antiviral agents active against the AIDS virus, TIPS Revs. 8:339 (1987).

    Google Scholar 

  65. Z.G. Wang, J. Ren and R. Zhang, Immunoregulatory studies of ammonium glycyrrhizinate in mice, Asia Pacific J. Pharmacol. 5:157 (1990).

    CAS  Google Scholar 

  66. W.E.G. Muller, B.E. Weiler, R. Charubala, W. Pfleiderer, L. Leserman, R.W. Sobol, R.J. Suhadolnik and H.C. Schroder, Cordycepin analogues of 2′,5′-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase, Biochemistry 30:2027 (1991).

    Article  PubMed  CAS  Google Scholar 

  67. T. Nakanishi, A. Inada and T. Kato, Antiviral cyclic triterpenoids from Patrinia. Patent to Sawai Pharmaceutical Co., Ltd., Jpn. Kokai Tokkyo Koho JP 01207262 (1989).

    Google Scholar 

  68. T.J. Smith, M.J. Kremer, M. Luo, et al., The site of attachment in human retrovirus for antiviral agents that inhibit uncoating, Science 233:1286 (1989).

    Article  Google Scholar 

  69. D.J. Capon and R.H.R. Ward, Immune antiviral effects of CD4 derivatives, Current Opin. 2:433 (1990).

    Article  CAS  Google Scholar 

  70. C. Flexner, P. Barditch-Crovo, D. Kornhauser, H. Farzadegan, L. Nerhood, R.E. Chaisson, K.M. Bell, K.J. Lorentsen, C.W. Hendrix, B. Petty and P. Leitman, Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection, Antimicrob. Agents Chemother. 35(12):2544 (1991).

    Article  PubMed  CAS  Google Scholar 

  71. K. Ono, H. Nakane, M. Fukushima, J.-C. Chermann and F. Barre-Sihoussi, Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases, Eur. J. Biochem. 190:469 (1990).

    Article  PubMed  CAS  Google Scholar 

  72. H. Nakane and K. Ono, Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases, Biochemistry 29(11):2841 (1990).

    Article  PubMed  CAS  Google Scholar 

  73. K. Ono, H. Nakane, M. Fukushima, J.-C. Chermann and F. Barre-Sinoussi, Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone, Biochem. Biophys. Res. Commun. 160(3):982 (1989).

    Article  PubMed  CAS  Google Scholar 

  74. K. Ono, H. Nakane, M. Fukushima, J.C. Chermann and F. Barre-Sinoussi, 1989, Inhibition of HIV-reverse transcriptase by a Kampo medicine, Sho-saikoto (TJ-9), 5th Int. AIDS Conference June 4–9 (1989).

    Google Scholar 

  75. G. Spedding, A. Ratty, and E. Middleton, Jr., Inhibition of reverse transcriptases by flavonoids, Antiviral Res. 12:99 (1989).

    Article  PubMed  CAS  Google Scholar 

  76. K. Ono, Herbal extracts and their components as a novel class of inhibitors for HIV-reverse transcriptase, Antiviral Res., (Suppl. l):53 (1990).

    Google Scholar 

  77. R. Jansen, B. Kunze, V. Wray, H. Reichenbach, E. Jurkiewicz, G. Hunsmann, and G. Hofle, Phenoxan: A novel inhibitor of HIV-1 infection in cell cultures from Polyangium sp.. strain P1 VO19 (myxobacteria), Liebigs Ann. Chem. 707 (1991).

    Google Scholar 

  78. W.B. Parker, M. Nishizawa, M.H. Fisher, N. Ye, K.-H. Lee and Y.-C. Cheng, Characterization of a novel inhibitor of human DNA polymerases: 3,4,5-tri-O-galloylquinic acid, Biochem. Pharmacol. 38(21):3759 (1989).

    Article  PubMed  CAS  Google Scholar 

  79. G.-I. Nonaka, I. Nishioka, M. Nishizawa, T. Yamagishi, Y. Kashiwada, G.E. Dutschman, A.J. Bodner, R.E. Kilkuskie, Y.-C. Cheng, and K.-H. Lee, Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells, J. Nat. Prods. 53(3):587 (1990).

    Article  CAS  Google Scholar 

  80. T. Tanaka, G.-I. Nonaka and I. Nishioka, Tannins and related compounds, XL. Revision of the structures of punicalin and punicalagin, and isolation and characterization of 2-O-galloylpunicalin from the bark of Punica granatum, L. Chem. Pharm. Bull. 34:650 (1986).

    Article  CAS  Google Scholar 

  81. H. Nakane and K. Ono, Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases, Biochemistry 29:2841 (1990).

    Article  PubMed  CAS  Google Scholar 

  82. W. Kreis, M.H. Kaplan, J. Freeman, D.K. Sun and P.S. Sarin, Inhibition of HIV replication by Hyssop officinalis extracts, Antiviral Res. 14:323 (1990).

    Article  PubMed  CAS  Google Scholar 

  83. H. Nakane, M. Fukushima and K. Ono, Differential inhibition of reverse transcriptase and various DNA polymerases by digallic acid and its derivatives, J. Nat. Prods. 53(5): 1234 (1990).

    Article  CAS  Google Scholar 

  84. T. Jacks, M.D. Power, F.R. Masiarz, P.A. Luciw, P.J. Barr, H.E. Varmus, Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (London) 331:280 (1988).

    Article  CAS  Google Scholar 

  85. V.A. Johnson, B.D. Walker, M.A. Barlow, TJ. Paradis, T.C. Chou and M.S. Hirsch, Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3′-azido-3′-deoxythymidine, Antimicrob. Agents Chemother. 33:53 (1989).

    Article  PubMed  CAS  Google Scholar 

  86. R.M. Ruprecht, S. Mullaney, J. Andersen and R. Bronson, In vivo analysis of castanospermine, a candidate antiretroviral agent, J AIDS 2:149 (1989).

    CAS  Google Scholar 

  87. P.S. Sunkara, D. Taylor, M. Kang, T. Bowlin, P. Liu, A. Tyms and A. Sjoerdsma, Anti-HIV activity of castanospermine analogs, Lancet 1:1206 (1989).

    Article  PubMed  CAS  Google Scholar 

  88. N.R. Kohl, E.A. Emini, W.A. Schleif, L.J. Davis, J.C. Heimbach, R.A. Dixon, E.M. Scolnick I.S. and Sigal, Active human immunodeficiency virus protease is required for viral infectivity, Proc. Natl. Acad. Sci., USA 85:4686 (1988).

    Article  PubMed  CAS  Google Scholar 

  89. C. Peng, B.K. Ho, T.W. Chang and N.T. Chang, Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity, J. Virol. 63:2550 (1989).

    PubMed  CAS  Google Scholar 

  90. H.G. Gottlinger, J.G. Sodroski and W.A. Haseltine, Role of the capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. USA 86:5781 (1989).

    Article  PubMed  CAS  Google Scholar 

  91. K. Von der Helm, L. Gurtler, J. Eberle and F. Deinhardt, Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A, FEBS Letters 247(2):349 (1989).

    Article  PubMed  Google Scholar 

  92. J.J. Blumenstein, T.D. Copeland, S. Oroszlan and C.J. Michejda, Synthetic non-peptide inhibitors of HIV protease, Biochem. Biophys. Res. Commun.163(2):980 (1989).

    Article  PubMed  CAS  Google Scholar 

  93. M.L. Bryant, R.O. Heuckeroth, J.T. Kimata, L. Ratner and J.I. Gordon, Replication of human immunodeficiency virus 1 and moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid, Proc. Natl. Acad. Sci. USA 86:8655 (1989).

    Article  PubMed  CAS  Google Scholar 

  94. D. Lewis, A.J. Baran, V. Knight and M. Jett, Inhibitory effects of unsaturated phospholipids on HIV production in vitro. Fifth International AIDS Conference, Montreal, Canada (1989).

    Google Scholar 

  95. K.R. Gustafson, J.H. Cardellina II, R.W. Fuller, O.S. Weislow, R.F. Kiser, K.M. Smader, G.M.L. Patterson and M.R. Boyd, AIDS-Antiviral sulfolipids from cyanobacteria (blue-green algae), J. Nat. Cancer Inst. 81(16): 1254 (1989).

    Article  PubMed  CAS  Google Scholar 

  96. J. Czajkowski, V. Tozzi and O. Strannegard, Suppression of HIV replication in vitro by fusidic parallels toxicity, J. Antimicrob. Agents Chemother. 23:155 (1989).

    Article  CAS  Google Scholar 

  97. R.F. Schinazi, B.F.H. Eriksson, B.H. Arnold, P. Lekas and M.S. McGrath, Effect of dehydroepiandrosterone in lymphocytes and macrophages infected with human immunodeficiency viruses in “The Biologic Role of Dehydroepiandrosterone (DHEA)” (Kalimi, M. and Regelson, W. eds.), Walter de Gruyter, Berlin, New York, p. 157 (1990).

    Google Scholar 

  98. D.D. Richman, H. Mitsuya, S. Broder and K.Y. Hostetler, Fusidic acid, HIV, and host cell toxicity, Lancet 1:1051 (1988).

    Article  PubMed  CAS  Google Scholar 

  99. M. Baba, D. Schols, H. Nakashima, R. Pauwels, G. Parmentier, D.K.F. Meijer and E. De Clercq, Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro. J. Acquir. Immun. Def. Synd. 2(3):264 (1989).

    CAS  Google Scholar 

  100. H.H. Sun, S.S. Cross, M. Gunasekara and F.E. Koehn, Weinbersterol disulfates A and B, antiviral steroid sulfates from the sponge Petrosia weinbergi, Tetrahedron 47(7): 1185 (1991).

    Article  CAS  Google Scholar 

  101. R. Pal, R.C. Gallo and M.G. Sarngadharan, Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin, Proc. Natl. Acad. Sci. USA 85:9283 (1988).

    Article  PubMed  CAS  Google Scholar 

  102. R.L. Dewar, M.B. Vasudevachari, V. Natarajan and N.P. Salzman, Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport, J. Virol. 63(6):2452 (1989).

    PubMed  CAS  Google Scholar 

  103. S. Olsnes, I.H. Madshus and K. Sandvig, K., Entry mechanisms of picornaviruses In “Virus Attachment and Entry into Cells” Proceedings of an ASM Conference Held in Philadelphia, Pennsylvania, 10–13 April 1985, 171–181 (Crowell, R. L. and Lonberg-Holm, K. eds.) (1986).

    Google Scholar 

  104. P.J. Maddon, A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss and R. Axel, The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain, Cell 47:333 (1986).

    Article  PubMed  CAS  Google Scholar 

  105. M. Nakamura, T. Ohno, S. Kunimoto, H. Naganawa and T. Takeuchi, Kijimicin: An inhibitor of human immunodeficiency virus in acutely and chronically infected cells, J. Antibiotics 44(5):569 (1991).

    Article  CAS  Google Scholar 

  106. P.K. Lai, J. Donovan, H. Takayama, H. Sakagami, A. Tanaka, K. Konno and M. Nonoyama, Modification of human immunodeficiency viral replication by pine cone extracts, AIDS Res. Hum. Retrovir. 6(6):205 (1990).

    Article  PubMed  CAS  Google Scholar 

  107. H. Takayama, G. Bradley, P.K. Lai, Y. Tamura, H. Sakagami, A. Tanaka, A., M. Nonoyama, Inhibition of human immunodeficiency virus forward and reverse transcription by PC6, a natural product from cones of pine trees, AIDS Res. Hum. Retrovir. 7(3):349 (1991).

    Article  PubMed  CAS  Google Scholar 

  108. D. Schols, P. Wutzler, R. Klocking, B. Helbig and E. De Clercq, Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against HIV replication, J. Acq. Immun. Deflc. Synd. 4:677 (1991).

    CAS  Google Scholar 

  109. E. Priel, S.D. Showalter and D.G. Blair, Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor, AIDS Res. Hum. Retrovir. 7(1):65 (1991).

    PubMed  CAS  Google Scholar 

  110. M. Baba, R. Pauwels, J. Balzarini, D. Schols and E. De Clercq, Coumermycin A1 is a potent inhibitor of human immunodeficiency virus (HIV) replication in vitro. Intr. J. Exp. Clin. Chemother. 2(1):15 (1989).

    CAS  Google Scholar 

  111. A. Turano, G. Scura, A. Caruso, C. Bonfanti, R. Luzzati, D. Bassetti, N. Manca, Inhibitory effect of papaverine on HIV replication in vitro. AIDS Res. Hum. Retrovir. 5(2):183 (1989).

    Article  PubMed  CAS  Google Scholar 

  112. G.T. Tan, J.M. Pezzuto, A.D. Kinghorn and S.A. Hughes, Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, J. Nat. Prods. 54(1): 143 (1991).

    Article  CAS  Google Scholar 

  113. W.J. Kassler, P. Blanc and R. Greenblatt, The use of medicinal herbs by human immunodeficiency virus-infected patients, Arch. Intern. Med. 151:2281 (1991).

    Article  PubMed  CAS  Google Scholar 

  114. G.T. Tan, J.M. Pezzuto and A.D. Kinghorn, Evaluation of natural products as inhibitors of human immunodeficiency virus (HIV) reverse transcriptase, Planta Med. (short lectures) 56:504 (1990).

    Article  Google Scholar 

  115. P. Hafkemeyer, K. Neftel, R. Hobbi, A. Pfaltz, H. Lutz, K. Luthi, F. Focher, S. Spadari and U. Hubscher, HO 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H, Nucleic Acid Res. 19:4059 (1991).

    Article  PubMed  CAS  Google Scholar 

  116. K.P. Manfredi, J.W. Blunt, J.H. Cardellina, J.B. McMahon, L.L. Pannell, G.M. Cragg and M.R. Boyd, Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2, J. Med. Chem. 34:3402 (1991).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, 20892, USA

    Mohamed Nasr, James Cradock & Margaret Johnston

Authors
  1. Mohamed Nasr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Cradock
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margaret Johnston
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The University of Georgia, Athens, Georgia, USA

    Chung K. Chu

  2. Agricultural Research Service, United States Department of Agriculture, Athens, Georgia, USA

    Horace G. Cutler

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nasr, M., Cradock, J., Johnston, M. (1992). Structure-Activity Correlations of Natural Products with Anti-HIV Activity. In: Chu, C.K., Cutler, H.G. (eds) Natural Products as Antiviral Agents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3414-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3414-3_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6509-9

  • Online ISBN: 978-1-4615-3414-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation